Emeline Cros

867 total citations
13 papers, 628 citations indexed

About

Emeline Cros is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Emeline Cros has authored 13 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Emeline Cros's work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Emeline Cros is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Emeline Cros collaborates with scholars based in France, Canada and United States. Emeline Cros's co-authors include Charles Dumontet, Carlos M. Galmarini, Lars Petter Jordheim, Xavier Thomas, Fabien Calvo, Philippe Rousselot, John R. Mackey, Kathryn Graham, Muriel Rabilloud and Christian Périgaud and has published in prestigious journals such as Blood, Oncogene and Clinical Cancer Research.

In The Last Decade

Emeline Cros

12 papers receiving 619 citations

Peers

Emeline Cros

HEMAT

ONCOL

PHYSI

PHEOH

JR Mackey Canada

Kamran Gharehbaghi Austria

Tatjana Spasokoukotskaja Sweden

MR Grever United States

E.Michael Egan United States

L Danhauser United States

Roninson Ib United States

G Pizzorno United States

M. Willy Honders Netherlands

Eric Laille United States

JR Mackey Canada

Emeline Cros

220 ×0.6

86 ×0.4

HEMAT

157 ×0.8

ONCOL

61 ×0.5

PHYSI

37 ×0.3

PHEOH

Citations per year, relative to Emeline Cros Emeline Cros (= 1×) peers JR Mackey

Countries citing papers authored by Emeline Cros

Since Specialization

Citations

This map shows the geographic impact of Emeline Cros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emeline Cros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emeline Cros more than expected).

Fields of papers citing papers by Emeline Cros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emeline Cros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emeline Cros. The network helps show where Emeline Cros may publish in the future.

Co-authorship network of co-authors of Emeline Cros

This figure shows the co-authorship network connecting the top 25 collaborators of Emeline Cros. A scholar is included among the top collaborators of Emeline Cros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emeline Cros. Emeline Cros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Reslan, Lina, et al.. (2010). Comparison of Cytotoxic Mechanisms of Anti-CD20 Antibodies GA101 and Rituximab Against Fresh Chronic Lymphocytic Leukemia Cells. Blood. 116(21). 2467–2467.

Jordheim, Lars Petter, Isabelle Lefèbvre, Emeline Cros, et al.. (2009). Special feature of mixed phosphotriester derivatives of cytarabine. Bioorganic & Medicinal Chemistry. 17(17). 6340–6347. 26 indexed citations

Jordheim, Lars Petter, Emeline Cros, Carlos M. Galmarini, et al.. (2006). F-ara-AMP is a substrate of cytoplasmic 5′-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. Nucleosides Nucleotides & Nucleic Acids. 25(3). 289–297. 13 indexed citations

Cros, Emeline, Lars Petter Jordheim, Charles Dumontet, & Carlos M. Galmarini. (2004). Problems Related to Resistance to Cytarabine in Acute Myeloid Leukemia. Leukemia & lymphoma. 45(6). 1123–1132. 57 indexed citations

Lee, Sanghoon, Carlos M. Galmarini, Rosita Accardi, et al.. (2004). Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia. Oncogene. 23(13). 2287–2297. 25 indexed citations

Galmarini, Carlos M., Marilyn L. Clarke, Lars Petter Jordheim, et al.. (2004). Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene. BMC Pharmacology. 4(1). 8–8. 58 indexed citations

Jordheim, Lars Petter, Emeline Cros, Carlos M. Galmarini, et al.. (2004). Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line. Clinical Cancer Research. 10(16). 5614–5621. 54 indexed citations

Galmarini, Carlos M., Marilyn L. Clarke, C.L. Santos, et al.. (2003). Sensitization of ara‐C‐resistant lymphoma cells by a pronucleotide analogue. International Journal of Cancer. 107(1). 149–154. 14 indexed citations

Galmarini, Carlos M., Xavier Thomas, Kathryn Graham, et al.. (2003). Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine. British Journal of Haematology. 122(1). 53–60. 72 indexed citations

10.

Galmarini, Carlos M., Nicole Falette, Lars Petter Jordheim, et al.. (2002). Influence of p53 and p21WAF1 expression on sensitivity of cancer cells to cladribine. Biochemical Pharmacology. 65(1). 121–129. 21 indexed citations

11.

Galmarini, Carlos M., Xavier Thomas, Fabien Calvo, et al.. (2002). In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. British Journal of Haematology. 117(4). 860–868. 120 indexed citations

12.

Galmarini, Carlos M., Xavier Thomas, Fabien Calvo, et al.. (2002). Potential mechanisms of resistance to cytarabine in AML patients. Leukemia Research. 26(7). 621–629. 96 indexed citations

13.

Galmarini, Carlos M., Kathryn Graham, Xavier Thomas, et al.. (2001). Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia. Blood. 98(6). 1922–1926. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact